GVINP1: A Protein Involved in Pain and Cell Signaling (G387751)
GVINP1: A Protein Involved in Pain and Cell Signaling
GVINP1 (G protein-coupled receptor type 1) is a protein that is expressed in many tissues throughout the body. It is a member of the G protein-coupled receptor family, which is a large superfamily of transmembrane proteins that play a critical role in cellular signaling. GVINP1 is one of the many proteins that belong to the G protein-coupled receptor family, and it is expressed in many different tissues, including the brain, heart, and kidneys.
GVINP1 is a protein that is known for its role in pain signaling. It is expressed in the endodermal tissue, which includes the brain and spinal cord, and it is involved in the development and progression of pain. GVINP1 is thought to play a key role in the development of chronic pain, as it is expressed in the brain and may contribute to the neuroinflammation that is observed in many chronic pain conditions.
In addition to its role in pain signaling, GVINP1 is also known for its role in the regulation of cell signaling. It is a component of the G protein-coupled receptor signaling pathway, which is a critical pathway that is involved in many cellular processes throughout the body. GVINP1 is thought to contribute to the regulation of a wide range of cellular processes, including cell growth, differentiation, and inflammation.
GVINP1 is also of interest as a potential drug target. Many diseases, including chronic pain and neuroinflammatory conditions, are characterized by the activation of over-active immune and inflammatory systems. GVINP1 is thought to be involved in the regulation of these processes, and targeting it may be a promising approach to the treatment of these diseases.
GVINP1 is also of interest as a potential biomarker. The expression of GVINP1 is often reduced in many diseases, including chronic pain and neuroinflammatory conditions. This may be an indicator that GVINP1 is involved in the development and progression of these conditions. By detecting changes in GVINP1 expression in individuals with chronic pain or neuroinflammatory conditions, researchers may be able to develop new diagnostic tests or therapeutic approaches.
In conclusion, GVINP1 is a protein that is expressed in many tissues throughout the body and is involved in the regulation of pain signaling and cell signaling. It is also thought to be involved in the development and progression of chronic pain and neuroinflammatory conditions. As a result, GVINP1 is of interest as a potential drug target and biomarker. Further research is needed to fully understand the role of GVINP1 in these processes and to develop new approaches to the treatment of chronic pain and neuroinflammatory conditions.
Protein Name: GTPase, Very Large Interferon Inducible Pseudogene 1
More Common Targets
GVQW3 | GXYLT1 | GXYLT1P3 | GXYLT1P4 | GXYLT1P6 | GXYLT2 | GYG1 | GYG2 | GYPA | GYPB | GYPC | GYPE | GYS1 | GYS2 | GZF1 | GZMA | GZMB | GZMH | GZMK | GZMM | H1-0 | H1-1 | H1-10 | H1-10-AS1 | H1-2 | H1-3 | H1-4 | H1-5 | H1-6 | H1-7 | H1-8 | H1-9P | H19 | H19-ICR | H2AB1 | H2AB2 | H2AB3 | H2AC1 | H2AC11 | H2AC12 | H2AC13 | H2AC14 | H2AC15 | H2AC16 | H2AC17 | H2AC18 | H2AC20 | H2AC21 | H2AC25 | H2AC3P | H2AC4 | H2AC6 | H2AC7 | H2AJ | H2AP | H2AX | H2AZ1 | H2AZ1-DT | H2AZ2 | H2AZ2-DT | H2AZP2 | H2BC1 | H2BC10 | H2BC11 | H2BC12 | H2BC12L | H2BC13 | H2BC14 | H2BC15 | H2BC17 | H2BC18 | H2BC20P | H2BC21 | H2BC26 | H2BC27P | H2BC3 | H2BC4 | H2BC5 | H2BC6 | H2BC7 | H2BC8 | H2BC9 | H2BP1 | H2BP2 | H2BP3 | H2BW1 | H2BW2 | H2BW4P | H3-3A | H3-3B | H3-4 | H3-5 | H3-7 | H3C1 | H3C10 | H3C11 | H3C12 | H3C13 | H3C14 | H3C15
